Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - CINCINNATI
['FUNDING_OTHER'] · UNIVERSITY OF CINCINNATI · NIH-11127343
This study is looking for new birth control methods that help prevent unintended pregnancies while also being safer for women who are obese, and by joining the trial, you can help create better options for women's health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CINCINNATI (nih funded) |
| Locations | 1 site (CINCINNATI, UNITED STATES) |
| Trial ID | NIH-11127343 on ClinicalTrials.gov |
What this research studies
This research focuses on creating new contraceptive methods that not only prevent unintended pregnancies but also minimize the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) will develop and implement clinical trial protocols aimed at testing these new contraceptive agents. By participating in these trials, patients may contribute to the advancement of safer and more effective contraceptive options tailored to women's health needs.
Who could benefit from this research
Good fit: Ideal candidates for participation are women, especially those who are obese or have medical conditions that make current contraceptive options unsuitable.
Not a fit: Patients who are not women or those who do not have a need for contraception may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer contraceptive methods that are effective for women, particularly those with obesity or other medical conditions.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, indicating that this approach could lead to significant advancements in women's health.
Where this research is happening
CINCINNATI, UNITED STATES
- UNIVERSITY OF CINCINNATI — CINCINNATI, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THOMAS, MICHAEL — UNIVERSITY OF CINCINNATI
- Study coordinator: THOMAS, MICHAEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.